Biotech by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech ranked by P/S ratio, at 3.8, followed by Qiagen (4.9) and Neurocrine Biosciences (5.9). Figures as of 18 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.8
Median
14.5
Combined market value
CZK 18.83T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

Biotech by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.8CZK 826.6BCZK 5,591.91 0.41% up 49% up United States
2QiagenQGEN · Health Care4.9CZK 228BCZK 1,104.08 0.06% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.9CZK 372.2BCZK 3,677.31 0.19% down 20% up United States
4BioNTechBNTX · Health Care6.6CZK 468.6BCZK 1,890.06 0.30% up 16% down Germany
5AmgenAMGN · Health Care6.7CZK 5.44TCZK 10,056.65 1.10% down 34% up United States
6Gilead SciencesGILD · Health Care7.1CZK 4.67TCZK 3,767.91 0.34% down 33% up United States
7ExelixisEXEL · Health Care7.2CZK 371.6BCZK 1,522.78 0.11% up 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.9CZK 243.6BCZK 2,136.77 0.27% up 37% up United States
9Bio-TechneTECH · Health Care9.4CZK 253.7BCZK 1,614.93 0.13% up 26% up United States
10argenxARGX · Health Care14.5CZK 1.34TCZK 21,321.98 1.34% up 4% up Belgium
11RepligenRGEN · Health Care14.7CZK 241.4BCZK 3,776.91 4.87% up 5% up United States
12Adaptive BiotechnologiesADPT · Health Care16.8CZK 103.4BCZK 638.64 0.95% up 88% up United States
13Twist BioscienceTWST · Health Care20.5CZK 171.6BCZK 2,516.38 1.18% up 340% up United States
14Krystal BiotechKRYS · Health Care23.0CZK 199BCZK 6,716.20 1.31% up 46% up United States
15ModernaMRNA · Health Care43.2CZK 1.86TCZK 4,605.97 0.30% up 755% up United States
16ImmunityBioIBRX · Health Care58.4CZK 146.9BCZK 138.12 0.64% down 193% up United States
17Kymera TherapeuticsKYMR · Health Care267CZK 232.7BCZK 2,726.23 1.03% up 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1161CZK 90.5BCZK 932.60 4.60% up 21% down Switzerland
19CG OncologyCGON · Health Care1755CZK 157.4BCZK 1,762.71 0.56% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2060 CZK). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech have the lowest P/S ratio?

Biogen (3.8), Qiagen (4.9) and Neurocrine Biosciences (5.9) have the lowest P/S ratio of the 19 biotech ranked here as of 18 Nov 2026, 14:43 UTC.

How many biotech are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 19 biotech ranked by P/S ratio have a combined market value of CZK 18.83T as of 18 Nov 2026, 14:43 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.